The DASH Diet and Insulin Sensitivity

Overview

Journal Curr Hypertens Rep

Specialty Cardiology & Vascular Diseases

Date 2010 Nov 9

PMID 21058045

Citations 33

Authors

Alan L Hinderliter

Michael A Babyak

Andrew Sherwood

James A Blumenthal

Affiliations

Soon will be listed here.

Abstract

Lifestyle modifications, including adoption of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern, weight loss in individuals who are overweight or obese, and physical activity, are effective in the prevention and treatment of hypertension. A healthy lifestyle may also have beneficial effects on metabolic abnormalities, such as insulin resistance, that are associated with high blood pressure. This review examines the independent and combined effects of the DASH diet and weight loss plus exercise on blood pressure and insulin sensitivity, with a focus on recently published results from the ENCORE study. Our data suggest that the DASH eating plan alone lowers blood pressure in overweight individuals with higher than optimal blood pressure, but significant improvements in insulin sensitivity are observed only when the DASH diet is implemented as part of a more comprehensive lifestyle modification program that includes exercise and weight loss.

Citing Articles

The Impact of 24 h Urinary Potassium Excretion on High-Density Lipoprotein Cholesterol and Chronic Disease Risk in Chinese Adults: A Health Promotion Study.

Du X, Chen X, Zhang J, Lu F, Xu C, Zhong J Nutrients. 2024; 16(19).

PMID: 39408253 PMC: 11478645. DOI: 10.3390/nu16193286.

Fueling the Heart: What Are the Optimal Dietary Strategies in Heart Failure?.

Ataran A, Pompian A, Hajirezaei H, Lodhi R, Javaheri A Nutrients. 2024; 16(18).

PMID: 39339757 PMC: 11434961. DOI: 10.3390/nu16183157.

Dietary Approaches to Stop Hypertension (DASH) and mortality risk among patients with liver cirrhosis: a prospective cohort study.

Zarei A, Pashayee-Khamene F, Hekmatdoost A, Karimi S, Ahmadzadeh S, Saberifiroozi M BMC Res Notes. 2024; 17(1):248.

PMID: 39232774 PMC: 11376012. DOI: 10.1186/s13104-024-06928-z.

Bridging the Gap: The Need to Implement Dietary Guidance to Address Cardiovascular Health.

Brown A, Adas S, de Jesus J, Farmer N, Fisher R, Pratt C Nutrients. 2024; 16(13).

PMID: 38999873 PMC: 11243232. DOI: 10.3390/nu16132125.

The determinants of fasting and post-load non-esterified fatty acids in older adults: The cardiovascular health study.

Bene-Alhasan Y, Siscovick D, Ix J, Kizer J, Tracy R, Djousse L Metabol Open. 2023; 20:100261.

PMID: 38115866 PMC: 10728567. DOI: 10.1016/j.metop.2023.100261.

References

Burstein R, Polychronakos C, Toews C, MacDougall J, Guyda H, Posner B . Acute reversal of the enhanced insulin action in trained athletes. Association with insulin receptor changes. Diabetes. 1985; 34(8):756-60. DOI: 10.2337/diab.34.8.756. View

Kannel W, Wilson P, Zhang T . The epidemiology of impaired glucose tolerance and hypertension. Am Heart J. 1991; 121(4 Pt 2):1268-73. DOI: 10.1016/0002-8703(91)90432-h. View

Vanninen E, Uusitupa M, Siitonen O, Laitinen J, Lansimies E . Habitual physical activity, aerobic capacity and metabolic control in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus: effect of 1-year diet and exercise intervention. Diabetologia. 1992; 35(4):340-6. DOI: 10.1007/BF00401201. View

Neal B, Macmahon S, Chapman N . Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet. 2000; 356(9246):1955-64. DOI: 10.1016/s0140-6736(00)03307-9. View

Julius S, Jamerson K, Mejia A, Krause L, Schork N, Jones K . The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure study. JAMA. 1990; 264(3):354-8. View

Wing R, Venditti E, Jakicic J, POLLEY B, Lang W . Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care. 1998; 21(3):350-9. DOI: 10.2337/diacare.21.3.350. View

Sacks F, Svetkey L, Vollmer W, Appel L, Bray G, Harsha D . Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001; 344(1):3-10. DOI: 10.1056/NEJM200101043440101. View

Gutt M, Davis C, Spitzer S, Llabre M, Kumar M, Czarnecki E . Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract. 2000; 47(3):177-84. DOI: 10.1016/s0168-8227(99)00116-3. View

Muniyappa R, Lee S, Chen H, Quon M . Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2007; 294(1):E15-26. DOI: 10.1152/ajpendo.00645.2007. View

10.

Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6):393-403. PMC: 1370926. DOI: 10.1056/NEJMoa012512. View

11.

Kannel W, Neaton J, Wentworth D, Thomas H, Stamler J, Hulley S . Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J. 1986; 112(4):825-36. DOI: 10.1016/0002-8703(86)90481-3. View

12.

Appel L, Champagne C, Harsha D, Cooper L, Obarzanek E, Elmer P . Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003; 289(16):2083-93. DOI: 10.1001/jama.289.16.2083. View

13.

Goodpaster B, Kelley D, Wing R, Meier A, Thaete F . Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes. 1999; 48(4):839-47. DOI: 10.2337/diabetes.48.4.839. View

14.

Elliott W, Meyer P . Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007; 369(9557):201-7. DOI: 10.1016/S0140-6736(07)60108-1. View

15.

Law M, Wald N, Morris J, Jordan R . Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003; 326(7404):1427. PMC: 162261. DOI: 10.1136/bmj.326.7404.1427. View

16.

Feinglos M, Totten S . Are you what you eat, or how much you eat? The case of type 2 diabetes mellitus. Arch Intern Med. 2008; 168(14):1485-6. DOI: 10.1001/archinte.168.14.1485. View

17.

Stamler J, Vaccaro O, Neaton J, Wentworth D . Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993; 16(2):434-44. DOI: 10.2337/diacare.16.2.434. View

18.

Trovati M, CARTA Q, Cavalot F, Vitali S, BANAUDI C, Lucchina P . Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients. Diabetes Care. 1984; 7(5):416-20. DOI: 10.2337/diacare.7.5.416. View

19.

Orozco L, Buchleitner A, Gimenez-Perez G, Roque I Figuls M, Richter B, Mauricio D . Exercise or exercise and diet for preventing type 2 diabetes mellitus. Cochrane Database Syst Rev. 2008; (3):CD003054. DOI: 10.1002/14651858.CD003054.pub3. View

20.

Dunder K, Lind L, Zethelius B, Berglund L, Lithell H . Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study. BMJ. 2003; 326(7391):681. PMC: 152364. DOI: 10.1136/bmj.326.7391.681. View